Komori
Secom (9735) · FactIncrease in R&D Expenses for the Interim Period

Research and Development Investment

First written in FY2017-Q1. 17 of 31 entries say "Restated". Latest entry: FY2027-H1.

31entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017-Q1 – FY2027-H12016: 22017: 320172018: 220182019: 320192020: 320202021: 420212022: 320222023: 420232024: 320242025: 220252026: 22026
Same theme, other companies
Continuation of Company-wide R&D Activities and Resource InvestmentA theme 227 companies write about · 1 as a headwind · 236 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 189 companies compared. The sentences above are computed from all 189.Comparing 200 of the theme's 239 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1Increase in R&D Expenses for the Interim PeriodAnnual report

    「Total research and development expenses for the interim period were ¥4,743 million.」

    Research and development expenditure for the interim period increased from ¥4,058 million in the same period of the previous year to ¥4,743 million.
  2. FY2026Increase in R&D ExpensesAnnual report

    「The group's total research and development expenditure for the consolidated fiscal year was ¥8,738 million,」

    Research and development expenditure increased from ¥8,186 million in the previous fiscal year to ¥8,738 million.
  3. FY2026-H1Increase in R&D Expenses for the Interim PeriodAnnual report

    「Total research and development expenses for the interim period were ¥4,058 million.」

    Research and development expenditure for the interim period increased from ¥3,850 million in the same period of the previous year to ¥4,058 million.
  4. FY2025Increase in R&D ExpensesAnnual report

    「The group's total research and development expenditure for the consolidated fiscal year was ¥8,186 million,」

    Research and development expenditure increased from ¥7,513 million in the previous fiscal year to ¥8,186 million. Research and development in AI, IoT, cybersecurity and other areas is continuing.
  5. FY2025-H1Increase in R&D Expenses for the Interim PeriodAnnual report

    「Total research and development expenses for the interim period were ¥3,850 million.」

    Research and development expenditure for the interim period increased from ¥3,409 million in the same period of the previous year to ¥3,850 million.
  6. FY2024Increase in R&D ExpensesAnnual report

    「The group's total research and development expenditure for the consolidated fiscal year was ¥7,513 million,」

    Research and development expenditure increased from ¥7,285 million in the previous fiscal year to ¥7,513 million. Research and development in AI, IoT, cybersecurity and other areas is continuing.
  7. FY2024-Q3Increase in R&D expenses for the first 3 quartersAnnual report

    「Total research and development expenses for the third quarter were ¥5,435 million.」

    Research and development expenditure for the cumulative third quarter was ¥5,435 million, up from ¥5,207 million in the same period of the previous year.
  8. FY2024-Q2Increase in second-quarter R&D expensesAnnual report

    「Total research and development expenses for the second quarter were ¥3,456 million.」

    Research and development expenditure for the cumulative second quarter was ¥3,456 million, up from ¥3,409 million in the same period of the previous year.
  9. FY2024-Q1First-quarter R&D expenditure declinedAnnual report

    「Total research and development expenditure for the first quarter was ¥1,624 million.」

    Research and development expenditure in the first quarter was ¥1,624 million, down from ¥1,695 million in the same period of the previous year.
  10. FY2023R&D expenses edged downAnnual report

    「The group's total research and development expenditure for the consolidated fiscal year was ¥7,285 million,」

    Research and development expenditure edged down from ¥7,305 million in the previous fiscal year to ¥7,285 million, but research and development in AI, IoT, cybersecurity and other areas is continuing.
  11. FY2023-Q3Decrease in third-quarter R&D expensesAnnual report

    「Total research and development expenses for the third quarter were ¥5,207 million.」

    Research and development expenditure in the third quarter was ¥5,207 million, down from ¥5,937 million in the same period of the previous year.
  12. FY2023-Q2RestatedAnnual report

    「Total research and development expenses for the second quarter were ¥3,419 million.」

    Quarterly actual research and development expenditure continues to be disclosed.
  13. FY2023-Q1First-quarter R&D expenditure declinedAnnual report

    「Total research and development expenses for the first quarter were ¥1,659 million.」

    Research and development expenditure in the first quarter was ¥1,659 million, down from ¥1,695 million in the same period of the previous year.
  14. FY2022Decline in R&D SpendingAnnual report

    「The group's total research and development expenditure for the consolidated fiscal year was ¥7,305 million,」

    Research and development expenditure declined from ¥8,059 million in the previous fiscal year to ¥7,305 million, but research and development in AI, IoT, cybersecurity and other areas is continuing.
  15. FY2022-Q2RestatedAnnual report

    「Total research and development expenditure for the second quarter was ¥3,409 million.」

    Quarterly actual research and development expenditure continues to be disclosed.
  16. FY2022-Q1RestatedAnnual report

    「Total research and development expenses for the first quarter were ¥1,695 million.」

    Quarterly actual research and development expenditure continues to be disclosed.
  17. FY2021RestatedAnnual report

    「The group's total research and development expenditure for the consolidated fiscal year was ¥8,059 million,」

    Annual research and development expenditure continues to be disclosed and increased from ¥7,167 million in the previous fiscal year to ¥8,059 million.
  18. FY2021-Q3RestatedAnnual report

    「Total research and development expenses for the third quarter were ¥5,937 million.」

    Quarterly actual research and development expenditure continues to be disclosed.
  19. FY2021-Q2RestatedAnnual report

    「Total research and development expenses for the second quarter were ¥3,916 million.」

    Quarterly actual research and development expenditure continues to be disclosed.
  20. FY2021-Q1RestatedAnnual report

    「Total research and development expenses for the first quarter were ¥1,945 million.」

    Quarterly actual research and development expenditure continues to be disclosed.
  21. FY2020-Q3RestatedAnnual report

    「Total research and development expenses for the third quarter were ¥5,071 million.」

    Quarterly actual research and development expenditure continues to be disclosed.
  22. FY2020-Q1RestatedAnnual report

    「Total research and development expenses for the first quarter were ¥1,544 million.」

    Quarterly actual research and development expenditure continues to be disclosed.
  23. FY2019RestatedAnnual report

    「The group's total research and development expenditure for the consolidated fiscal year was ¥7,334 million,」

    Annual actual research and development expenditure was disclosed, confirming the continuation of research and development investment.
  24. FY2019-Q3RestatedAnnual report

    「Total research and development expenses for the third quarter were ¥5,056 million.」

    Actual research and development expenditure continues to be disclosed.
  25. FY2019-Q2RestatedAnnual report

    「Total research and development expenses for the second quarter were ¥3,378 million.」

    Actual research and development expenditure continues to be disclosed.
  26. FY2018-Q3RestatedAnnual report

    「Total research and development expenses for the third quarter were ¥5,373 million.」

    Actual research and development expenditure continues to be disclosed.
  27. FY2018-Q2RestatedAnnual report

    「Total research and development expenses for the second quarter were ¥3,458 million.」

    Actual research and development expenditure continues to be disclosed.
  28. FY2018-Q1RestatedAnnual report

    「Total research and development expenses for the first quarter were ¥1,662 million.」

    Actual research and development expenditure continues to be disclosed.
  29. FY2017-Q3RestatedAnnual report

    「Total research and development expenses for the third quarter were ¥4,667 million.」

    Actual research and development expenditure continues to be disclosed.
  30. FY2017-Q2RestatedAnnual report

    「Total research and development expenses for the second quarter were ¥3,046 million.」

    Actual research and development expenditure continues to be disclosed.
  31. FY2017-Q1First statedAnnual report

    「Total research and development expenses for the first quarter were ¥1,547 million.」

    Actual research and development expenditure for the quarter has been disclosed.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Secom yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.